Clínica Baviera, S.A.
Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia…
Medical - Diagnostics & Research
ES, Madrid [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | -19.46 | 20.55 | 25.52 | |
| Graham Fair Price | 39.93 | 10.41 | 7.44 | |
| PEG | -1.37 | 0.17 | 0.17 | |
| Price/Book | -4.64 | 4.41 | 4.63 | |
| Price/Cash Flow | -40.94 | 33.68 | 57.02 | |
| Prices/Earnings | -21.19 | 9.16 | 11.62 | |
| Price/Sales | -0.20 | 6.85 | 6.86 | |
| Price/FCF | -40.94 | 33.68 | 57.02 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | 0.00 | 1.00 | 1.00 | |
| Operating Margin | 16.30 | 0.25 | 0.22 | |
| ROA | 26.29 | 0.06 | 0.05 | |
| ROE | 0.10 | 0.12 | 21.00 | |
| ROIC | 0.07 | 0.08 | 15.26 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | -0.02 | 0.02 | 5.41 | |
| Dividends QOQ | -0.78 | -1.00 | -28.42 | |
| EBIT QOQ | 0.80 | 0.26 | -67.61 | |
| EPS QOQ | 0.69 | 0.55 | -20.10 | |
| FCF QOQ | 0.12 | 0.83 | 569.65 | |
| Revenue QOQ | 0.29 | 0.08 | -71.12 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Weak
Fundamentals
Leverage & Liquidity
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 0.00 | 0.00 | 0.00 | |
| Days Sales Outstanding (DSO) | 4.42 | 0.00 | inf | |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | |
| Debt/Capitalization | 0.34 | 0.31 | -9.28 | |
| Quick Ratio | 1.20 | 1.42 | 18.10 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 4.97 | 6.33 | 27.21 | |
| Cash | 2.80 | 3.71 | 32.33 | |
| Capex | -0.47 | -0.42 | 10.52 | |
| Free Cash Flow | 0.40 | 0.83 | 105.40 | |
| Revenue | 3.35 | 4.07 | 21.55 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Best
Fundamentals
Financial Health
06 - Financial Health ·
Weak